Tehran University of Medical Sciences

Science Communicator Platform

Share By
Prone Position in Management of Covid-19 Patients; a Commentary Publisher



Ghelichkhani P1 ; Esmaeili M2
Authors

Source: Archives of Academic Emergency Medicine Published:2020


Abstract

SARS-CoV-2 virus causes a pneumonia that was identified through fever, dyspnea, and acute respiratory symptoms and named COVID-19. This disease exacerbates in a number of patients and causes pulmonary edema, multi-organ failure, and acute respiratory distress syndrome (ARDS). Prevalence of ARDS among COVID-19 patients has been reported to be up to 17%. Among the introduced treatment methods for management of ARDS patients, prone position can be used as an adjuvant therapy for improving ventilation in these patients. Here we reviewed the literature regarding the role of prone position inmanagement of COVID-19 patients. © 2020 All Rights Reserved
Related Docs
View other Related Docs
1. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
2. Lung Transplantation As a Way to Escape Pneumonia in Patients With Covid-19: Lessons From Ards and Influenza, Acta Medica Indonesiana (2021)
3. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Amir Reza Radmard (1)
Other Related Docs
4. Extrapulmonary Manifestations of Covid-19: Radiologic and Clinical Overview, Clinical Imaging (2020)
5. Covid-19 Presenting As Right Flank Pain in a Postpartum Woman: A Case Report, Annals of Medicine and Surgery (2021)
6. Biochemical Parameters and Pathogenesis of Sars-Cov-2 Infection in Vital Organs: Covid-19 Outbreak in Iran, New Microbes and New Infections (2020)
7. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
8. Clinical Course, Imaging Features, and Outcomes of Covid-19 in Kidney Transplant Recipients, European Urology (2020)
9. Risk Factors of Developing Critical Conditions in Iranian Patients With Covid-19, Global Epidemiology (2021)
10. The Involvement of the Central Nervous System in Patients With Covid-19, Reviews in the Neurosciences (2020)
11. Acute Myocarditis and Acute Myopathy As the First Manifestations of Covid-19; a Case Report, Journal of Nephropharmacology (2023)
12. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
13. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
14. Adverse Outcome and Severity of Covid-19 in Patients With Autoimmune Bullous Diseases: A Historical Cohort Study, Dermatologic Therapy (2022)
15. Extracorporeal Hemoperfusion As a Potential Therapeutic Option for Severe Covid-19 Patients; a Narrative Review, Archives of Academic Emergency Medicine (2020)
16. Spontaneous Pneumomediastinum, Pneumopericardium, Pneumothorax, and Subcutaneous Emphysema in a Patient With Covid-19, Radiology Case Reports (2021)
17. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
18. The Role of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphism in the Severity and Outcomes of Covid-19 Patients, Frontiers in Genetics (2022)
19. A Perspective on Erythropoietin As a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients With Covid-19, Archives of Medical Research (2020)
20. Efficacy and Safety of Corticosteroids in Covid-19 Based on Evidence for Covid-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis, CMAJ (2020)